Clinical Trials in Arizona

Showing 7921-7940 of 12,706 trials

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

NCT01770353

This is a Phase I study to understand the biodistribution of MM-398 and to determine the feasibility of using Ferumoxytol as a tumor imaging agent.

Solid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more

Ipsen45 participantsStarted Nov 2012

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • San Francisco, California, United States +4 more locations

COMPLETEDNA31 miles

ImageReady(TM) MR Conditional Pacing System Clinical Study

NCT01781078

The objective of the SAMURAI Clinical Study is to collect data to confirm the safety, performance and effectiveness of the ImageReady System for use in the Magnetic Resonance Imaging (MRI) environment when used in accordance with the Conditions of Use included in the Boston Scientific MRI Technical Guide

BradycardiaSinus Node Dysfunction

Boston Scientific Corporation363 participantsStarted Feb 2013

Mesa, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +38 more locations

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

ImageReady(TM) MR Conditional Pacing System Clinical Study

Find Trials by Condition in Arizona

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

HW006 LATERAL Thoracotomy

Post Market Surveillance Study of the Wingspan Stent System

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

Safety and Efficacy of PRP for Treatment of Disc Pain

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

A Clinical Trial of IntensiVE Dialysis